Chongqing Runze Pharmaceutical Co., Ltd.

Chongqing Runze Pharmaceutical Co., Ltd. was established in 2007 and is headquartered in the Airport Industrial Park. It is a high-tech enterprise deeply engaged in the field of orthopedic implants, integrating R&D, production, and marketing.
We focus on the clinical application of innovative medical materials such as multi-level porous tantalum. Porous tantalum is known as "bone-like metal" for its excellent biocompatibility and superior toughness. The company currently has an R&D center and has assembled an interdisciplinary expert team covering fields such as materials science, metallurgy, biomechanics, and intelligent manufacturing.
The company attaches great importance to independent innovation, brand building, and the protection of independent intellectual property rights. It has successively undertaken projects such as the National 863 Program, the National Science and Technology Support Program, and the National Science and Technology Innovation Fund, and has received honors and awards including the "National Science and Technology Progress Award" and "Major Scientific and Technological Achievement of the PLA Logistics in the Eleventh Five-Year Plan." At present, the company has obtained multiple national invention patents and international patents, owns multiple self-owned brand registered trademarks such as "Runze" and "Runergu," and is a "Member Unit of the China Patent Protection Association," a "National Intellectual Property Demonstration Enterprise," a "National Patent Operation Pilot Enterprise," and a "National Intellectual Property Advantage Enterprise."
The company persists in intellectual property R&D and has cumulatively obtained more than 1,300 domestic and foreign patent authorizations. It attaches great importance to R&D investment, with annual R&D investment accounting for more than 10% of annual sales revenue. The company jointly established the Institute of Medical Mesoscopic Materials and has set up laboratories for structure, mechanics, composition, biology, and electrical testing. It is the world's first enterprise to implement full inspection of implantable products using CAE technology.
With the mission of "enabling everyone to stand up," the vision of "becoming a guide in bone regeneration materials," and the corporate values of "innovation, truth-seeking, integrity, responsibility, efficiency, and win-win," the company provides a win-win and shared work platform for those with aspirations. We will devote ourselves to the continuous exploration of bone regeneration materials, enabling patients to stand up without dependence and live happy lives, and contributing to human health!